Down bad and don’t know what you’re sick with? Thrixen has got the quick and affordable solution to find out. Their tech allows you to find out what kind of disease or infection you have in minutes.

Now, they’ve just raised $7M in funding!

Investor check. The round was co-led by 22Health Ventures and John Ballantyne (co-founder, Aldevron).

‍

🩸 How it works

They’re developing rapid test technology that will be able to distinguish between both bacterial and viral infections in 10 minutes. With just your fingerprick!

• How? The multiplex diagnostic test can simultaneously analyze samples for multiple disease-causing organisms (pathogens).
• This would be the first time that multiplex testing is offered at point-of-care.

If developed successfully, these will allow essential diagnostics tests to be easily brought to patients.

• They’ll be simple and quick to do, while being affordable enough to offer at scale.

‍

💰 What’s next?

They’ll keep building their diagnostic technology platform. 22Health’s investment will also unlock accelerated access to the US market and management guidance.

• They’re also developing the initial use cases for clinical trials to bring the product to market.